FC
ELV icon

Fairscale Capital’s Elevance Health ELV Stock Holding History

Fairscale Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.05K Hold
7
– – ﹤0.01% 387
2025
Q4 		$2.45K Sell
7
-58
-89% -$19.6K ﹤0.01% 368
2025
Q3 		$21K Hold
65
– – 0.01% 270
2025
Q2 		$18.4K Buy
65
+58
+829% +$23.3K 0.01% 278
2025
Q1 		$3.04K Hold
7
– – ﹤0.01% 288
2024
Q4 		$2.58K Hold
7
– – ﹤0.01% 294
2024
Q3 		$3.64K Hold
7
– – ﹤0.01% 286
2024
Q2 		$3.87K Buy
+7
New +$3.7K ﹤0.01% 284

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Fairscale Capital's ELV Position: Q1 2026 in Review

Fairscale Capital held its Elevance Health (ELV) position steady in Q1 2026 at 7 shares worth $2.05K. The position accounts for ﹤0.01% of the portfolio, ranked #387.

Fairscale Capital first reported a position in ELV in Q2 2024 and has held it in 8 quarters since. The position peaked at $21K in Q3 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Fairscale Capital held 7 shares of Elevance Health worth $2.05K as of Q1 2026.
  • Fairscale Capital left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up ﹤0.01% of Fairscale Capital's portfolio in Q1 2026, its #387 holding.
  • Fairscale Capital first reported a position in Elevance Health in Q2 2024 and has held it in 8 quarters since.
  • Fairscale Capital's Elevance Health position peaked at $21K in Q3 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Fairscale Capital's 13F filing for Q1 2026, filed 11 May 2026.